- Home
- RARE vs TBBB Comparison
RARE vs TBBB Comparison
Compare RARE & TBBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- TBBB
- Stock Information
- Founded
- RARE 2010
- TBBB 2004
- Country
- RARE United States
- TBBB Mexico
- Employees
- RARE N/A
- TBBB N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- TBBB
- Sector
- RARE Health Care
- TBBB
- Exchange
- RARE Nasdaq
- TBBB NYSE
- Market Cap
- RARE 4.2B
- TBBB 3.3B
- IPO Year
- RARE 2014
- TBBB 2024
- Fundamental
- Price
- RARE $42.59
- TBBB $28.03
- Analyst Decision
- RARE Strong Buy
- TBBB Buy
- Analyst Count
- RARE 15
- TBBB 7
- Target Price
- RARE $93.13
- TBBB $29.86
- AVG Volume (30 Days)
- RARE 656.5K
- TBBB 1.6M
- Earning Date
- RARE 02-13-2025
- TBBB 03-04-2025
- Dividend Yield
- RARE N/A
- TBBB N/A
- EPS Growth
- RARE N/A
- TBBB N/A
- EPS
- RARE N/A
- TBBB 0.12
- Revenue
- RARE $560,230,000.00
- TBBB $2,727,305,465.00
- Revenue This Year
- RARE $19.26
- TBBB $32.56
- Revenue Next Year
- RARE $36.92
- TBBB $29.46
- P/E Ratio
- RARE N/A
- TBBB $235.96
- Revenue Growth
- RARE 29.01
- TBBB 29.70
- 52 Week Low
- RARE $37.02
- TBBB $19.31
- 52 Week High
- RARE $60.37
- TBBB $35.22
- Technical
- Relative Strength Index (RSI)
- RARE 44.76
- TBBB N/A
- Support Level
- RARE $41.73
- TBBB N/A
- Resistance Level
- RARE $44.98
- TBBB N/A
- Average True Range (ATR)
- RARE 1.72
- TBBB 0.00
- MACD
- RARE -0.04
- TBBB 0.00
- Stochastic Oscillator
- RARE 18.03
- TBBB 0.00
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About TBBB BBB FOODS INC
BBB Foods Inc is a company offering grocery hard discount model in Mexico. Also that operates through three subsidiaries namely Tiendas Tres B , Tiendas BBB and Desarrolladora Tres BSA de CV of which the main activity of Tiendas Tres B is the sale, purchase, distribution and marketing of all types of products, items and goods, as well as the establishment, and operation of individual stores and distribution centers for the sale of such products.